NCT02277314

Brief Summary

The overall objective is to determine the visual outcomes and cost to perform Manual Small Incision Cataract Surgery (MSICS) in a small cohort at an academic medical center in the United States. The primary outcome measure will be the percentage of the study group achieving a post operative visual acuity 20/40 Snellen. This percentage will be compared to historical cohorts reported for phacoemulsification cataract surgery (PCS), when performed in academic centers. A secondary outcome will be to determine the actual institutional cost of providing MSICS in the setting of an academic medical center. The hypothesis is that MSICS is appropriate for a teaching environment (as evidenced by a comparable rate of 20/40 acuity or better at 90 days post op, as compared to PCS), and can be provided at a cost that makes visual rehabilitation affordable to the uninsured and underinsured.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 24, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 29, 2014

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

January 13, 2016

Status Verified

January 1, 2016

Enrollment Period

2 years

First QC Date

October 24, 2014

Last Update Submit

January 11, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Manual Small Incision Cataract Surgery with outcomes of 20/40 or better at the end of a year and with spectacle correction

    Post-cataract surgery the subject must have a visual acuity of 20/40 or better with spectacle correction

    2 years

Study Arms (1)

Low Cost Treatment for Cataracts

OTHER

Low cost, manual small incision cataract surgery performed in an educational environment. All costs covered by subjects.

Procedure: Manual Small Incision Cataract Surgery

Interventions

This cost-effective solution for removing cataracts, also known as Manual Small Incision Cataract Surgery (MSICS), is a positive alternative when Phaco is not an option due to costs. The procedure takes approximately 30 minutes and involves a mid-size incision and an intraocular lens (IOL), or artificial lens, replacing the natural lens. Following the procedure, patients may need glasses, and most will need bifocals, but overall vision will be significantly improved.

Also known as: MSICS
Low Cost Treatment for Cataracts

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 21 years or older (adults).
  • Medically Stable, able to safely undergo surgery.
  • Nuclear sclerotic cataract
  • Preoperative best corrected visual acuity (BCVA) 20/80 or worse
  • Expected post-operative potential acuity of 20/40 or better
  • Able to pay the $500 cost of surgery at the time of surgery

You may not qualify if:

  • Potential subjects not satisfying any of the above

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arizona Medical Center Alvernon Physician Offices

Tucson, Arizona, 85711, United States

RECRUITING

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Joseph M Miller, MD, PhD

    University of Arizona Department of Ophthalmology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sue A Bulau, BA, AAS

CONTACT

Jill E Brickman-Kelleher, BS, AAS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Joseph Miller, MD, MPH

Study Record Dates

First Submitted

October 24, 2014

First Posted

October 29, 2014

Study Start

April 1, 2014

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

January 13, 2016

Record last verified: 2016-01

Locations